Antal Desai Biography and Net Worth

Director of PROCEPT BioRobotics


Mr. Desai has served as a member of our board of directors since June 2015. Mr. Desai joined Cardinal Investment Company, Inc. in September 2004, the predecessor firm to CPMG, Inc., an investment firm that invests in publicly-traded and private companies globally, were he currently serves as a Partner. Mr. Desai is a member of the board of directors of several private companies. Mr. Desai received both a B.S. in Economics and an M.B.A. from the Wharton School at the University of Pennsylvania.

What is Antal Rohit Desai's net worth?

The estimated net worth of Antal Rohit Desai is at least $14.28 million as of September 12th, 2024. Mr. Desai owns 197,453 shares of PROCEPT BioRobotics stock worth more than $14,277,826 as of October 11th. This net worth approximation does not reflect any other investments that Mr. Desai may own. Learn More about Antal Rohit Desai's net worth.

How do I contact Antal Rohit Desai?

The corporate mailing address for Mr. Desai and other PROCEPT BioRobotics executives is 900 ISLAND DRIVE, REDWOOD CITY CA, 94065. PROCEPT BioRobotics can also be reached via phone at 650-232-7200 and via email at [email protected]. Learn More on Antal Rohit Desai's contact information.

Has Antal Rohit Desai been buying or selling shares of PROCEPT BioRobotics?

Antal Rohit Desai has not been actively trading shares of PROCEPT BioRobotics within the last three months. Most recently, Antal Rohit Desai sold 44,867 shares of the business's stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $80.11, for a transaction totalling $3,594,295.37. Following the completion of the sale, the director now directly owns 197,453 shares of the company's stock, valued at $15,817,959.83. Learn More on Antal Rohit Desai's trading history.

Who are PROCEPT BioRobotics' active insiders?

PROCEPT BioRobotics' insider roster includes Antal Desai (Director), Frederic Moll (Director), Kevin Waters (EVP, CFO), and Reza Zadno (CEO). Learn More on PROCEPT BioRobotics' active insiders.

Are insiders buying or selling shares of PROCEPT BioRobotics?

In the last twelve months, insiders at the sold shares 29 times. They sold a total of 564,842 shares worth more than $31,363,074.91. The most recent insider tranaction occured on September, 16th when CFO Kevin Waters sold 25,000 shares worth more than $2,062,750.00. Insiders at PROCEPT BioRobotics own 17.4% of the company. Learn More about insider trades at PROCEPT BioRobotics.

Information on this page was last updated on 9/16/2024.

Antal Rohit Desai Insider Trading History at PROCEPT BioRobotics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/12/2024Sell44,867$80.11$3,594,295.37197,453View SEC Filing Icon  
9/10/2024Sell36,500$76.18$2,780,570.00281,018View SEC Filing Icon  
9/5/2024Sell13,305$76.37$1,016,102.85317,518View SEC Filing Icon  
9/3/2024Sell35,220$76.12$2,680,946.4023,963View SEC Filing Icon  
See Full Table

Antal Rohit Desai Buying and Selling Activity at PROCEPT BioRobotics

This chart shows Antal Rohit Desai's buying and selling at PROCEPT BioRobotics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

PROCEPT BioRobotics Company Overview

PROCEPT BioRobotics logo
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Read More

Today's Range

Now: $73.48
Low: $72.36
High: $73.79

50 Day Range

MA: $74.08
Low: $56.31
High: $84.99

2 Week Range

Now: $73.48
Low: $24.83
High: $85.81

Volume

76,201 shs

Average Volume

596,469 shs

Market Capitalization

$3.78 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.03